Point72 Asset Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.15M Sell
71,700
-247,800
-78% -$19.1M 0.01% 1687
2025
Q4
$25.4M Buy
+319,500
New +$25.2M 0.03% 752
2025
Q2
Sell
-18,300
Closed -$1.24M 2264
2025
Q1
$1.24M Buy
+18,300
New +$1.1M ﹤0.01% 1381
2024
Q1
Sell
-2,500
Closed -$197K 2262
2023
Q4
$197K Buy
+2,500
New +$178K ﹤0.01% 1814
2023
Q3
Sell
-8,000
Closed -$553K 2530
2023
Q2
$553K Hold
8,000
﹤0.01% 1243
2023
Q1
$594K Sell
8,000
-47,700
-86% -$4M ﹤0.01% 1201
2022
Q4
$5.19M Buy
55,700
+9,000
+19% +$868K 0.02% 744
2022
Q3
$4.45M Hold
46,700
0.02% 757
2022
Q2
$4.33M Buy
+46,700
New +$4.56M 0.02% 746

Other funds holding CVS

Point72 Asset Management's CVS Position: Q1 2026 in Review

Point72 Asset Management sold out of CVS Health (CVS) in Q1 2026, closing a stake of 2,088,622 shares — an estimated $161M sold.

Point72 Asset Management first reported a position in CVS in Q3 2014 and held it in 25 quarters. The position peaked at $166M in Q4 2025. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Point72 Asset Management reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
  • Point72 Asset Management sold 2,088,622 CVS Health shares in Q1 2026, an estimated $161M.
  • Point72 Asset Management first reported a position in CVS Health in Q3 2014 and held it in 25 quarters.
  • Point72 Asset Management's CVS Health position peaked at $166M in Q4 2025.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.